Among them, XRCC1 Arg399Gln, Arg280His, and Arg194Trp, XRCC3 Thr241Met, and XPD Lys751Gln polymorphisms are the most studied in cancers, including leukemia. This evidence concerns the gene ERCC2 and cancer.